Axsome Therapeutics Inc (MEX:AZSM)
MXN 1519 0 (0%) Market Cap: 85.66 Bil Enterprise Value: 83.20 Bil PE Ratio: 0 PB Ratio: 42.15 GF Score: 39/100

Axsome Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 06:55PM GMT
Release Date Price: MXN1247
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Okay. Let's go ahead and get started. Welcome, everyone. This is the fireside chat with Axsome Therapeutics. My name is Vikram Purohit. I'm one of the biotech analysts with Morgan Stanley Research. Before we get started, I need to read a brief disclosure statement. For important disclosures, please see the Morgan Stanley Research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. With that, happy to have with me, Herriot Tabuteau, CEO of Axsome. Herriot, thanks for joining us.

Herriot Tabuteau
Axsome Therapeutics, Inc. - Founder, Chairman, CEO & President

Thank you. Thanks for having us.

Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Of course. Herriot, we have quite a few areas in the pipeline and also our ability to talk about,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot